What are you looking for today?

Hill, Rebecca M, Kuijper, Sanne, Lindsey, Janet C, Petrie, Kevin, Schwalbe, Ed C, Barker, Karen, Boult, Jessica K R, Williamson, Daniel, Ahmad, Zai, Hallsworth, Albert, Ryan, Sarra L, Poon, Evon, Robinson, Simon P, Ruddle, Ruth, Raynaud, Florence I, Howell, Louise, Kwok, Colin, Joshi, Abhijit, Nicholson, Sarah Leigh, Crosier, Stephen, Wharton, Stephen B, Robson, Keith, Michalski, Antony, Hargrave, Darren, Jacques, Thomas S, Pizer, Barry, Bailey, Simon, Swartling, Fredrik J, Weiss, William A, Chesler, Louis and Clifford, Steven C (2014) Abstract MB-013: MYC and TP53 defects interact at medulloblastoma relapse to define rapidly progressive disease and can be targeted therapeutically. Neuro-Oncology, 16 (Sup 1). i74-i74. ISSN 1522-8517

Full text not available from this repository. (Request a copy)

Abstract

Abstract

Relapse following multi-modal therapy is the most adverse event in medul- loblastoma. Currently .90% of relapsing patients die, accounting for ~10% of childhood cancer deaths. Medulloblastoma is heterogeneous at diagnosis, comprising four molecular subgroups with distinct clinicopathological and molecular features. The relevance of these features at relapse is unknown, making characterisation, modelling and targeted therapy of relapse biology essential to improve outcomes. We undertook a comprehensive investigation of the molecular and clinicopathological features of 29 relapsed medulloblastomas and paired tumour samples taken at diagnosis, including the assessment of features with established significance at diagnosis (e.g. TP53 pathway status, MYC/MYCN amplification and molecular subgroup status). Molecular subgroup was unchanged, however evidence of alteration of all other features examined was found at relapse, with the majority of changes (30/44) representing acquired high-risk events. Most notably, MYC gene family amplifications and TP53 pathway defects commonly emerged in combination at relapse following conventional multimodal treatment (P 1⁄4 0.02, 7/ 22, 32%) and predicted rapid progression to death (P 1⁄4 0.016). Spontaneous development of Trp53 inactivating mutations was similarly common in a transgenic model of MYCN driven medulloblastoma (GTML;Glt1-tTA/ TRE-MYCN-Luc). Direct modelling of this interaction in GTML/Trp53KI/KI mice enhanced medulloblastoma formation (100%, 43/43 vs. 6%, 3/50 in GTML; P , 0.0001), mimicked clinicopathological characteristics of TP53-MYC relapsed human tumours, and validated the role of TP53 in potentiating the growth of MYCN-driven medulloblastoma. Therapeutic inhibition of Aurora-A kinase using MLN8237 in these tumours, and in derived neurospheres in vitro, promoted degradation of MYCN, reduced tumour growth and prolonged survival. In summary, medulloblastomas display altered molecular, pathological and clinical features at relapse and the emergence of combined TP53-MYC gene family defects is common following conventional therapy. Their association with rapid demise, and their validation as driving and therapeutically exploitable events in a novel mouse model, strongly support routine biopsy at relapse to drive future therapeutic strategies.

Item Type: Article
Uncontrolled Keywords: chemotherapy, regimen, child, medulloblastoma, diagnosis, neoplasms
Depositing User: Kevin Petrie
URI: https://sure.sunderland.ac.uk/id/eprint/15827

Further Details

More Information

Uncontrolled Keywords
chemotherapy, regimen, child, medulloblastoma, diagnosis, neoplasms
Depositing User

Identifiers

Item ID
15827
ISSN
1522-8517

Users with ORCIDS

ORCID for Kevin Petrie

Catalogue record

Date Deposited
22 Mar 2023 15:51
Last Modified
04 Jun 2025 16:18

Contributors

Author
Rebecca M Hill
Author
Sanne Kuijper
Author
Janet C Lindsey
Author
Ed C Schwalbe
Author
Karen Barker
Author
Jessica K R Boult
Author
Daniel Williamson
Author
Zai Ahmad
Author
Albert Hallsworth
Author
Sarra L Ryan
Author
Evon Poon
Author
Simon P Robinson
Author
Ruth Ruddle
Author
Florence I Raynaud
Author
Louise Howell
Author
Colin Kwok
Author
Abhijit Joshi
Author
Sarah Leigh Nicholson
Author
Stephen Crosier
Author
Stephen B Wharton
Author
Keith Robson
Author
Antony Michalski
Author
Darren Hargrave
Author
Thomas S Jacques
Author
Barry Pizer
Author
Simon Bailey
Author
Fredrik J Swartling
Author
William A Weiss
Author
Louis Chesler
Author
Steven C Clifford

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)